[PLX] QoQ Quarter Result on 30-Sep-2010 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Nov-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- 75.36%
YoY- 58.03%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 764 6,000 1,176 3,184 1,141 1,141 388 57.29%
PBT 179 -5,052 22,414 0 0 -7,955 31,440 -96.84%
Tax 20,699 0 -20,470 -374 -109 0 -16,504 -
NP -13,689 -5,052 -8,528 -2,474 -10,041 -7,955 -14,936 -5.66%
Tax Rate -11,563.69% - 91.33% - - - 52.49% -
Total Cost 14,453 11,052 9,704 5,658 11,182 9,096 15,324 -3.83%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin -1,791.75 -84.20 -725.17 -77.70 -880.02 -697.20 -3,849.48 -40.02%
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
EPS -0.16 -0.06 -1.04 -0.03 -0.12 -0.10 -1.85 -80.53%
EPS Diluted -0.16 -0.06 -1.04 -0.03 -0.12 -0.10 -1.85 -80.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.